71 results
Type of content
News Remove News filter
Documents Remove Documents filter
Events Remove Events filter
Patient safety
Yes Remove Yes filter
-
List item
Press release: EMA restricts use of prostate cancer medicine Xofigo
CHMP, Last updated: 27/07/2018 -
List item
Press release: Esmya: new measures to minimise risk of rare but serious liver injury
CHMP, Last updated: 01/06/2018 -
List item
Press release: EMA review of Zinbryta confirms medicine's risks outweigh its benefits
PRAC, Last updated: 18/05/2018 -
List item
Press release: New study suggests risk of birth defects in babies born to women on HIV medicine dolutegravir
PRAC, Last updated: 18/05/2018 -
List item
Press release: EMA reviewing risk of dosing errors with methotrexate
PRAC, Last updated: 13/04/2018 -
List item
Press release: Updated measures for pregnancy prevention during retinoid use
CHMP, Last updated: 23/03/2018 -
List item
Press release: Prostate cancer medicine Xofigo must not be used with Zytiga and prednisone/prednisolone
PRAC, Last updated: 09/03/2018 -
List item
Press release: EMA urgently reviewing multiple sclerosis medicine Zinbryta following cases of inflammatory brain disorders
PRAC, Last updated: 02/03/2018 -
List item
Press release: PRAC recommends new measures to avoid valproate exposure in pregnancy
PRAC, Last updated: 09/02/2018 -
List item
Press release: Women taking Esmya for uterine fibroids to have regular liver tests while EMA review is ongoing
PRAC, Last updated: 09/02/2018 -
List item
Press release: Defect with Buccolam oral syringes
CHMP, Last updated: 15/01/2018 -
List item
Press release: EMA concludes review of Zinbryta and confirms further restrictions to reduce risk of liver damage
CHMP, Last updated: 10/11/2017 -
List item
Press release: PRAC recommends further restrictions for multiple sclerosis medicine Zinbryta due to risk of serious liver damage
PRAC, Last updated: 27/10/2017 -
List item
Press release: EMA starts new review of hydroxyethyl-starch containing medicines
PRAC, Last updated: 27/10/2017 -
List item
Press release: Review of flupirtine-containing medicines started
PRAC, Last updated: 27/10/2017 -
List item
Press release: Direct-acting antivirals for hepatitis C: EMA confirms recommendation to screen for hepatitis B
CHMP, Last updated: 16/12/2016 -
List item
Press release: CHMP confirms recommendations for use of Zydelig
CHMP, Last updated: 22/07/2016 -
List item
Press release: PRAC concludes review of Zydelig and issues updated recommendations for use
PRAC, Last updated: 08/07/2016 -
List item
Press release: EMA recommends new safety measures for Zydelig
PRAC, Last updated: 18/03/2016 -
List item
Press release: EMA confirms recommendations to minimise risk of brain infection PML with Tysabri
CHMP, Last updated: 26/02/2016 -
List item
Press release: EMA confirms recommendations to minimise ketoacidosis risk with SGLT2 inhibitors for diabetes
CHMP, Last updated: 26/02/2016 -
List item
Press release: EMA recommends avoidance of certain hepatitis C medicines and amiodarone together
CHMP, Last updated: 24/04/2015 -
List item
Press release: GVK Biosciences: European Medicines Agency recommends suspending medicines over flawed studies
CHMP, Last updated: 23/01/2015 -
List item
Press release: European Medicines Agency recommends measures to reduce risk of heart problems with Corlentor/Procoralan (ivabradine)
CHMP, Last updated: 21/11/2014 -
List item
Press release: European Medicines Agency completes review of polymyxin-based medicines
CHMP, Last updated: 24/10/2014